Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation

Keywords: Thalassaemia intermedia, Siriraj I Gγ(Aγδβ)0-thalassaemia, IVS 1-1 (G-T) INTRODUCTION β-thalassaemia is an autosomal haematological disorder resulting in genetic lesions which include all or part of the β-globin gene complex.1 This inherited disorder was originally characteristic of the tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Malaysian journal of pathology 2021-04, Vol.43 (1), p.95-100
Hauptverfasser: Ying, Ying Ying, Alauddin, Hafza, Raja, Raja Zahratul Azma, Ithnin, Azlin, Jalil, Norunaluwar, Latiff, Zarina Abdul, Loh, C-Khai, Alias, Hamidah, Othman, Ainoon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 1
container_start_page 95
container_title Malaysian journal of pathology
container_volume 43
creator Ying, Ying Ying
Alauddin, Hafza
Raja, Raja Zahratul Azma
Ithnin, Azlin
Jalil, Norunaluwar
Latiff, Zarina Abdul
Loh, C-Khai
Alias, Hamidah
Othman, Ainoon
description Keywords: Thalassaemia intermedia, Siriraj I Gγ(Aγδβ)0-thalassaemia, IVS 1-1 (G-T) INTRODUCTION β-thalassaemia is an autosomal haematological disorder resulting in genetic lesions which include all or part of the β-globin gene complex.1 This inherited disorder was originally characteristic of the tropics and subtropics region but is now worldwide due to migratory fuxes from different countries and eventually present as a global public health problem.2 It is estimated that approximately 1% to 5% of the global population carries thalassaemia mutations.3 In Malaysia, thalassaemia is the commonest single gene disorder with a carrier rate of 4.5% to 6%.4 The human β-globin gene cluster resides within 80 kilobases (kb) on the short arm of chromosome 11.5 This complex is structurally arranged and developmentally expressed in the order of 5' e-Gγ-Aγ-δ-β. Both conventional method (gel electrophoresis, capillary electrophoresis or high-performance liquid chromatography) and advanced method (DNA analysis) are required. Peripheral blood flm showed hypochromic microcytic red blood cells and marked anisopoikilocytosis with the presence of target cells, schistocytes, polychromatic cells, nucleated red blood cell and Howell-Jolly bodies. Whereas, heterozygotes for δβ-thalassaemia have a modest increase of HbF (5-20%) with hypochromic microcytic red cell and heterocellular distribution of F-cells in Kleihauer test.11 The molecular characterisation is crucial for differential diagnosis as compound heterozygosity of HPFH and β thalassaemia behaves clinically as thalassaemia minor in opposition to co-inheritance of δβ thalassaemia and β thalassaemia which may give rise to β thalassaemia major.12 In our case, the heterozygous father and sister have raised HbF level (29.4% and 30.7% respectively) with a heterocellular distribution of F-cells and hypochromic microcytic red blood cells.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2546151798</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2546151798</sourcerecordid><originalsourceid>FETCH-proquest_journals_25461517983</originalsourceid><addsrcrecordid>eNqNis0OATEURrsg8fsON7Fh0WSKGTNLEX9rYisNl-nEtPS2hKVHEs_hmUzExs7qOznnK7FqILoRj6NeWGE1oiwIon6SxFV2XyirrMxgDlNoD-H1fD06AXepPEgiibmSsJGelN4D4Rktwk9T2qHNcftB2Jj8aLzeQoqFNrfr3ngCctIhXJRLYb5aCC7aU77sQO4Lr4xusPJOHgib362z1mS8HM340ZqTR3LrzHiri7Tuhv1IhGKQxL3_Xm9wP1Dj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546151798</pqid></control><display><type>article</type><title>Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ying, Ying Ying ; Alauddin, Hafza ; Raja, Raja Zahratul Azma ; Ithnin, Azlin ; Jalil, Norunaluwar ; Latiff, Zarina Abdul ; Loh, C-Khai ; Alias, Hamidah ; Othman, Ainoon</creator><creatorcontrib>Ying, Ying Ying ; Alauddin, Hafza ; Raja, Raja Zahratul Azma ; Ithnin, Azlin ; Jalil, Norunaluwar ; Latiff, Zarina Abdul ; Loh, C-Khai ; Alias, Hamidah ; Othman, Ainoon</creatorcontrib><description>Keywords: Thalassaemia intermedia, Siriraj I Gγ(Aγδβ)0-thalassaemia, IVS 1-1 (G-T) INTRODUCTION β-thalassaemia is an autosomal haematological disorder resulting in genetic lesions which include all or part of the β-globin gene complex.1 This inherited disorder was originally characteristic of the tropics and subtropics region but is now worldwide due to migratory fuxes from different countries and eventually present as a global public health problem.2 It is estimated that approximately 1% to 5% of the global population carries thalassaemia mutations.3 In Malaysia, thalassaemia is the commonest single gene disorder with a carrier rate of 4.5% to 6%.4 The human β-globin gene cluster resides within 80 kilobases (kb) on the short arm of chromosome 11.5 This complex is structurally arranged and developmentally expressed in the order of 5' e-Gγ-Aγ-δ-β. Both conventional method (gel electrophoresis, capillary electrophoresis or high-performance liquid chromatography) and advanced method (DNA analysis) are required. Peripheral blood flm showed hypochromic microcytic red blood cells and marked anisopoikilocytosis with the presence of target cells, schistocytes, polychromatic cells, nucleated red blood cell and Howell-Jolly bodies. Whereas, heterozygotes for δβ-thalassaemia have a modest increase of HbF (5-20%) with hypochromic microcytic red cell and heterocellular distribution of F-cells in Kleihauer test.11 The molecular characterisation is crucial for differential diagnosis as compound heterozygosity of HPFH and β thalassaemia behaves clinically as thalassaemia minor in opposition to co-inheritance of δβ thalassaemia and β thalassaemia which may give rise to β thalassaemia major.12 In our case, the heterozygous father and sister have raised HbF level (29.4% and 30.7% respectively) with a heterocellular distribution of F-cells and hypochromic microcytic red blood cells.</description><identifier>ISSN: 0126-8635</identifier><language>eng</language><publisher>Kuala Lumpur: College of Pathologists, Academy of Medicine of Malaysia</publisher><subject>Anemia ; Asymptomatic ; Blood ; Blood diseases ; Blood transfusions ; Cellulose acetate ; Chelation therapy ; Chromatography ; Deoxyribonucleic acid ; DNA ; Genes ; Genotype &amp; phenotype ; Hematology ; Hemoglobin ; Iron ; Mutation ; Polymerase chain reaction</subject><ispartof>Malaysian journal of pathology, 2021-04, Vol.43 (1), p.95-100</ispartof><rights>Copyright College of Pathologists, Academy of Medicine of Malaysia Apr 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Ying, Ying Ying</creatorcontrib><creatorcontrib>Alauddin, Hafza</creatorcontrib><creatorcontrib>Raja, Raja Zahratul Azma</creatorcontrib><creatorcontrib>Ithnin, Azlin</creatorcontrib><creatorcontrib>Jalil, Norunaluwar</creatorcontrib><creatorcontrib>Latiff, Zarina Abdul</creatorcontrib><creatorcontrib>Loh, C-Khai</creatorcontrib><creatorcontrib>Alias, Hamidah</creatorcontrib><creatorcontrib>Othman, Ainoon</creatorcontrib><title>Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation</title><title>Malaysian journal of pathology</title><description>Keywords: Thalassaemia intermedia, Siriraj I Gγ(Aγδβ)0-thalassaemia, IVS 1-1 (G-T) INTRODUCTION β-thalassaemia is an autosomal haematological disorder resulting in genetic lesions which include all or part of the β-globin gene complex.1 This inherited disorder was originally characteristic of the tropics and subtropics region but is now worldwide due to migratory fuxes from different countries and eventually present as a global public health problem.2 It is estimated that approximately 1% to 5% of the global population carries thalassaemia mutations.3 In Malaysia, thalassaemia is the commonest single gene disorder with a carrier rate of 4.5% to 6%.4 The human β-globin gene cluster resides within 80 kilobases (kb) on the short arm of chromosome 11.5 This complex is structurally arranged and developmentally expressed in the order of 5' e-Gγ-Aγ-δ-β. Both conventional method (gel electrophoresis, capillary electrophoresis or high-performance liquid chromatography) and advanced method (DNA analysis) are required. Peripheral blood flm showed hypochromic microcytic red blood cells and marked anisopoikilocytosis with the presence of target cells, schistocytes, polychromatic cells, nucleated red blood cell and Howell-Jolly bodies. Whereas, heterozygotes for δβ-thalassaemia have a modest increase of HbF (5-20%) with hypochromic microcytic red cell and heterocellular distribution of F-cells in Kleihauer test.11 The molecular characterisation is crucial for differential diagnosis as compound heterozygosity of HPFH and β thalassaemia behaves clinically as thalassaemia minor in opposition to co-inheritance of δβ thalassaemia and β thalassaemia which may give rise to β thalassaemia major.12 In our case, the heterozygous father and sister have raised HbF level (29.4% and 30.7% respectively) with a heterocellular distribution of F-cells and hypochromic microcytic red blood cells.</description><subject>Anemia</subject><subject>Asymptomatic</subject><subject>Blood</subject><subject>Blood diseases</subject><subject>Blood transfusions</subject><subject>Cellulose acetate</subject><subject>Chelation therapy</subject><subject>Chromatography</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Genes</subject><subject>Genotype &amp; phenotype</subject><subject>Hematology</subject><subject>Hemoglobin</subject><subject>Iron</subject><subject>Mutation</subject><subject>Polymerase chain reaction</subject><issn>0126-8635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqNis0OATEURrsg8fsON7Fh0WSKGTNLEX9rYisNl-nEtPS2hKVHEs_hmUzExs7qOznnK7FqILoRj6NeWGE1oiwIon6SxFV2XyirrMxgDlNoD-H1fD06AXepPEgiibmSsJGelN4D4Rktwk9T2qHNcftB2Jj8aLzeQoqFNrfr3ngCctIhXJRLYb5aCC7aU77sQO4Lr4xusPJOHgib362z1mS8HM340ZqTR3LrzHiri7Tuhv1IhGKQxL3_Xm9wP1Dj</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Ying, Ying Ying</creator><creator>Alauddin, Hafza</creator><creator>Raja, Raja Zahratul Azma</creator><creator>Ithnin, Azlin</creator><creator>Jalil, Norunaluwar</creator><creator>Latiff, Zarina Abdul</creator><creator>Loh, C-Khai</creator><creator>Alias, Hamidah</creator><creator>Othman, Ainoon</creator><general>College of Pathologists, Academy of Medicine of Malaysia</general><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20210401</creationdate><title>Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation</title><author>Ying, Ying Ying ; Alauddin, Hafza ; Raja, Raja Zahratul Azma ; Ithnin, Azlin ; Jalil, Norunaluwar ; Latiff, Zarina Abdul ; Loh, C-Khai ; Alias, Hamidah ; Othman, Ainoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_25461517983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anemia</topic><topic>Asymptomatic</topic><topic>Blood</topic><topic>Blood diseases</topic><topic>Blood transfusions</topic><topic>Cellulose acetate</topic><topic>Chelation therapy</topic><topic>Chromatography</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Genes</topic><topic>Genotype &amp; phenotype</topic><topic>Hematology</topic><topic>Hemoglobin</topic><topic>Iron</topic><topic>Mutation</topic><topic>Polymerase chain reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ying, Ying Ying</creatorcontrib><creatorcontrib>Alauddin, Hafza</creatorcontrib><creatorcontrib>Raja, Raja Zahratul Azma</creatorcontrib><creatorcontrib>Ithnin, Azlin</creatorcontrib><creatorcontrib>Jalil, Norunaluwar</creatorcontrib><creatorcontrib>Latiff, Zarina Abdul</creatorcontrib><creatorcontrib>Loh, C-Khai</creatorcontrib><creatorcontrib>Alias, Hamidah</creatorcontrib><creatorcontrib>Othman, Ainoon</creatorcontrib><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>East &amp; South Asia Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Malaysian journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ying, Ying Ying</au><au>Alauddin, Hafza</au><au>Raja, Raja Zahratul Azma</au><au>Ithnin, Azlin</au><au>Jalil, Norunaluwar</au><au>Latiff, Zarina Abdul</au><au>Loh, C-Khai</au><au>Alias, Hamidah</au><au>Othman, Ainoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation</atitle><jtitle>Malaysian journal of pathology</jtitle><date>2021-04-01</date><risdate>2021</risdate><volume>43</volume><issue>1</issue><spage>95</spage><epage>100</epage><pages>95-100</pages><issn>0126-8635</issn><abstract>Keywords: Thalassaemia intermedia, Siriraj I Gγ(Aγδβ)0-thalassaemia, IVS 1-1 (G-T) INTRODUCTION β-thalassaemia is an autosomal haematological disorder resulting in genetic lesions which include all or part of the β-globin gene complex.1 This inherited disorder was originally characteristic of the tropics and subtropics region but is now worldwide due to migratory fuxes from different countries and eventually present as a global public health problem.2 It is estimated that approximately 1% to 5% of the global population carries thalassaemia mutations.3 In Malaysia, thalassaemia is the commonest single gene disorder with a carrier rate of 4.5% to 6%.4 The human β-globin gene cluster resides within 80 kilobases (kb) on the short arm of chromosome 11.5 This complex is structurally arranged and developmentally expressed in the order of 5' e-Gγ-Aγ-δ-β. Both conventional method (gel electrophoresis, capillary electrophoresis or high-performance liquid chromatography) and advanced method (DNA analysis) are required. Peripheral blood flm showed hypochromic microcytic red blood cells and marked anisopoikilocytosis with the presence of target cells, schistocytes, polychromatic cells, nucleated red blood cell and Howell-Jolly bodies. Whereas, heterozygotes for δβ-thalassaemia have a modest increase of HbF (5-20%) with hypochromic microcytic red cell and heterocellular distribution of F-cells in Kleihauer test.11 The molecular characterisation is crucial for differential diagnosis as compound heterozygosity of HPFH and β thalassaemia behaves clinically as thalassaemia minor in opposition to co-inheritance of δβ thalassaemia and β thalassaemia which may give rise to β thalassaemia major.12 In our case, the heterozygous father and sister have raised HbF level (29.4% and 30.7% respectively) with a heterocellular distribution of F-cells and hypochromic microcytic red blood cells.</abstract><cop>Kuala Lumpur</cop><pub>College of Pathologists, Academy of Medicine of Malaysia</pub></addata></record>
fulltext fulltext
identifier ISSN: 0126-8635
ispartof Malaysian journal of pathology, 2021-04, Vol.43 (1), p.95-100
issn 0126-8635
language eng
recordid cdi_proquest_journals_2546151798
source EZB-FREE-00999 freely available EZB journals
subjects Anemia
Asymptomatic
Blood
Blood diseases
Blood transfusions
Cellulose acetate
Chelation therapy
Chromatography
Deoxyribonucleic acid
DNA
Genes
Genotype & phenotype
Hematology
Hemoglobin
Iron
Mutation
Polymerase chain reaction
title Siriraj I G (A δβ)0-thalassaemia causing severe thalassaemia intermedia in compound heterozygous state with IVS1-1(G-T) mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A14%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Siriraj%20I%20G%20(A%20%CE%B4%CE%B2)0-thalassaemia%20causing%20severe%20thalassaemia%20intermedia%20in%20compound%20heterozygous%20state%20with%20IVS1-1(G-T)%20mutation&rft.jtitle=Malaysian%20journal%20of%20pathology&rft.au=Ying,%20Ying%20Ying&rft.date=2021-04-01&rft.volume=43&rft.issue=1&rft.spage=95&rft.epage=100&rft.pages=95-100&rft.issn=0126-8635&rft_id=info:doi/&rft_dat=%3Cproquest%3E2546151798%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2546151798&rft_id=info:pmid/&rfr_iscdi=true